A company can report substantial sales and still have a different story unfolding inside working capital. Revenue records commercial activity. It does not tell you exactly when customer cash arrives, when suppliers must be paid, or how long money remains tied up between those points.
That distinction sits at the centre of Sanofi’s working-capital programme. The interesting part is not simply that a large company tried to “improve cash flow.” It is the way the business separated several timing signals and gave them explicit measures.
The business was not looking only at revenue
Sanofi’s treasury team worked with banking partners on a targeted working-capital programme. According to Citi’s case study, the work examined accounts-payable and accounts-receivable patterns across markets, including supplier payment terms and opportunities to monetise receivables.
The programme tracked measures including days payable outstanding, days sales outstanding, free cash flow and operating-efficiency goals. That created a different view of performance: not simply how much had been sold, but how long cash remained inside the operating cycle.
Receivables and payables tell different parts of the story
A sale can be recognised before cash is collected. A supplier may need to be paid before customer money arrives. When those timings move in opposite directions, a company may need to finance the gap even while headline commercial activity appears healthy.
This is why working capital is useful as an observation layer. Receivables show when customer cash arrives. Payables show when supplier cash leaves. The cash-conversion cycle helps connect those movements into time.
The programme reported a shorter cash cycle
Citi reported that Sanofi reduced its cash-conversion cycle by 10 percent within 12 to 18 months. The same case study reported an 11 percent improvement in supply-chain working capital and an €800 million accounts-receivable purchase programme.
Those numbers are material, but they need attribution. Citi was a programme partner, so the figures are partner-reported programme outcomes rather than the result of an independent controlled study.
What the case does — and does not — show
The evidence supports that Sanofi implemented a structured working-capital programme and that the programme reported measurable changes. It does not prove that those changes caused Sanofi’s overall growth, profitability or competitive performance.
For BOL, that limitation does not make the case less useful. The useful observation is narrower: a business can be commercially active while timing inside receivables, payables and the cash cycle tells a different operational story.
Why timing deserves its own view
Working capital often becomes visible only when something feels tight. But by then the business is already reacting. A more useful operating habit is to watch the timing variables while conditions still look normal: how quickly customers pay, how payment terms are changing, and how much cash is committed before collection.
This does not mean every company should optimise for the longest possible supplier terms or the shortest possible customer terms. Commercial relationships matter. The point is visibility: a deliberate trade-off is different from discovering the cash gap after it has already constrained a decision.
A cash signal can change the next question
If revenue is rising while the cash cycle is stretching, the next question may not be “how do we sell more?” It may be “what is funding this growth?” If receivables are stable but inventory is increasing, the pressure may sit elsewhere. The signal changes where the business looks next.
That is why BOL treats cash flow as a territory rather than a single ratio. The useful observation comes from movement across time and from the interaction between sales, collection, inventory and payment commitments.
Observe the gap before it becomes the problem
A working-capital problem often appears to management as a consequence: a payment is delayed, a planned investment is postponed, or short-term financing becomes necessary. The earlier signal is the gap itself. Customer cash is moving one way in time while supplier obligations, inventory and operating costs are moving another.
Tracking the gap does not tell the business what decision to make automatically. It tells the business where to look before assuming that more sales will solve the pressure. In some situations, more sales can increase the amount of cash temporarily tied up.
Follow movement across the same time window
Working-capital signals become more useful when the same measures are compared over a consistent window. A single DSO number can move because of customer mix or one large payment. A recurring drift across several periods is harder to dismiss as noise.
The same discipline applies to smaller businesses without formal treasury teams. The scale changes, but the observation remains: compare what has been sold, what has been collected, what must be paid and how those timings are moving together.
BOL Observation
Revenue tells you what was sold. Working capital can tell you how long the cash behind those sales remains inside the system.
Two businesses can record similar revenue and experience very different cash pressure. One collects quickly. Another waits. One pays suppliers after customer cash arrives. Another must fund the gap first.
The headline sales number may look similar while the operating reality is not.
Evidence boundary
The working-capital figures are reported by Citi, a programme partner. They support the existence of the intervention and the reported programme outcomes; they do not establish that the programme caused Sanofi’s wider business performance.
A signal is not a conclusion.
Look at your own business
Want to look at your own business?
Prefer the condensed version?
Case sources